REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19-Reference-Cited by-同舟云学术

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19

Published:2021-12-02 Issue:23 Volume:385 Page:e81
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Weinreich David M.¹,Sivapalasingam Sumathi¹,Norton Thomas¹,Ali Shazia¹,Gao Haitao¹,Bhore Rafia¹,Xiao Jing¹,Hooper Andrea T.¹,Hamilton Jennifer D.¹,Musser Bret J.¹,Rofail Diana¹,Hussein Mohamed¹,Im Joseph¹,Atmodjo Dominique Y.¹,Perry Christina¹,Pan Cynthia¹,Mahmood Adnan¹,Hosain Romana¹,Davis John D.¹^ORCID,Turner Kenneth C.¹,Baum Alina¹,Kyratsous Christos A.¹,Kim Yunji¹,Cook Amanda¹,Kampman Wendy¹,Roque-Guerrero Lilia¹,Acloque Gerard¹,Aazami Hessam¹,Cannon Kevin¹,Simón-Campos J. Abraham¹,Bocchini Joseph A.¹,Kowal Bari¹,DiCioccio A. Thomas¹,Soo Yuhwen¹,Geba Gregory P.¹,Stahl Neil¹,Lipsich Leah¹,Braunstein Ned¹,Herman Gary¹,Yancopoulos George D.¹

Affiliation:

1. From Regeneron Pharmaceuticals, Tarrytown (D.M.W., T.N., S.A., H.G., R.B., J.X., A.T.H., J.D.H., B.J.M., D.R., M.H., J.I., D.Y.A., C. Perry, C. Pan, A.M., R.H., J.D.D., K.C.T., A.B., C.A.K., Y.K., A.C., W.K., B.K., A.T.D., Y. S., G.P.G., N.S., L.L., N.B., G.H., G.D.Y.) and Excision BioTherapeutics, New York (S.S.) — both in New York; Bio-Medical Research (L.R.-G.) and Universal Medical and Research Center (G.A.) — both in Miami; Hope Clinical Research, Canoga Park, CA (H.A.); PMG Research of Wilmington,...

Funder

Regeneron Pharmaceuticals

Biomedical Advanced Research and Development Authority of the Department of Health and Human Services

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2108163

Cited by 674 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity;Nature Communications;2024-02-05

2. A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19;International Journal of Biological Macromolecules;2024-02

3. Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data;Frontiers in Immunology;2024-01-30

4. Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19;Annals of Pharmacotherapy;2024-01-30

5. Metaverse in Dynamic Viral-shedding Surveillance for Emerging Infectious Disease: A Digital Twin Approach to COVID-19 Epidemic;2024-01-29